Genmab — September 2015
-
ja, vi kan håbe at den selskabsspecifikke dagsorden for GEN kan rive den væk fra den almindelige pharma/biotek udvikling
-
det er da godt at Nordnetterne er klar på en omgang støtteopkøb!!
-
Vi må håbe, at han gør en rigtig god handel

-
Mon ikke snart insider-vinduet er lukket, så vi kan komme videre med nogle seriøse deals?
-
Nyt studie: HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors (A Phase Ib, Dose Escalation, Multiple Dose Trial With HuMax-IL8 in Patients With Metastatic or Unresectable, Locally Advanced Malignant Solid Tumors). https://clinicaltrials.gov/ct2/show/NCT02536469?term=cormorant&rank=1
-
Nice - dejligt med udbygning af klinikken
-
Ikke Nice med anonymt storsalg.

-
Næh - det må du nok sige. US futter nede med næsten 3% over hele linien
-
Det "gode" ved futter i -3% er at downside sjældent er helt enorm
-
Enig JKY.

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind